Note: The material presented in this commentary is provided for informational purposes only and is based upon information that is considered to be reliable. However, neither PSW Investments, LLC d/b/a PhilStockWorld (PSW) nor its affiliates warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.
Contact us: support@philstockworld.com
© Copyright - PSW, LLC.
2024
December 15th, 2014 at 4:21 pm
I have a highly speculative trade for the group. I have been following Opko (OPK) for 3-4 years and bought in at $4 then sold when it spiked to over $12 a while back. Got back in when it dipped back under $8 in the spring I think. Today they announced a deal with Pfizer on one of their many promising pipeline items that brings $295 mil in revenue with another $275 if they meet regulatory approvals. The chairman is Dr. Philip Frost who has made a career of building and selling companies that made fortunes for investors. He has been buying shares in the open market on a daily basis, so I have to believe he is planning to do it again. He is very old and this is extremely risky, but I wouldn't bet against but his guy, as so many short sellers are doing.